Prognostic factors in renal cell carcinoma: Analysis of 227 patients treated at the Brazilian national cancer institute

International Braz J Urol

Volumn 38, Issue 2, 2012, Pages 185-194

  Ornellas, Antonio Augusto ^a   Andrade, Dennyson M ^a   Ornellas, Paulo ^a   Wisnescky, Aristóteles ^a   de Santos Schwindt, Aline B ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Kidney; Neoplasms; Nephrectomy; Outcomes

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CANCER STAGING; CHILD; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; LYMPH NODE; MALE; METASTASIS; MIDDLE AGED; MORTALITY; NEPHRECTOMY; ORGANIZATION; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; TUMOR INVASION; VERY ELDERLY;

ACADEMIES AND INSTITUTES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CARCINOMA, RENAL CELL; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEPHRECTOMY; PROGNOSIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84865401251     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382012000200006     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 2009; 59: 225-49.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74-108.
3. Brasil. Ministério da Saúde. Instituto Nacional de Câncer. Estimativa 2010: incidência de câncer no Brasil. Instituto Nacional de Câncer. Rio de Janeiro, INCA, 2009; pp. 98
4. Nardi AC, Zequi Sde C, Clark OA, Almeida JC, Glina S: Epidemiologic characteristics of renal cell carcinoma in Brazil. Int Braz J Urol. 2010; 36: 151-7; discussion 158.
5. Van Poppel H, Becker F, Cadeddu JA, Gill IS, Janetschek G, Jewett MA, et al.: Treatment of localised renal cell carcinoma. Eur Urol. 2011; 60: 662-72.
6. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML: Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003; 27: 612-24.
7. Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, et al.: Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005; 23: 2763-71.
8. Thompson RH, Kurta JM, Kaag M, Tickoo SK, Kundu S, Katz D, et al.: Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol. 2009; 181: 2033-6.
9. Han KR, Bui MH, Pantuck AJ, Freitas DG, Leibovich BC, D FJ, et al.: TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. J Urol. 2003; 169: 899-903; discussion 903-4.
10. Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, et al.: Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? J Urol. 2005; 174: 1218-21.
11. Anderson CB, Clark PE, Morgan TM, Stratton KL, Herrell SD, Davis R, et al.: Urinary collecting system invasion is a predictor for overall and disease-specific survival in locally invasive renal cell carcinoma. Urology. 2011; 78: 99-104.
12. Feifer A, Savage C, Rayala H, Lowrance W, Gotto G, Sprenkle P, et al.: Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma cases. J Urol. 2011; 185: 37-42.
13. Ficarra V, Martignoni G, Lohse C, Novara G, Pea M, Cavalleri S, et al.: External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol. 2006; 175: 1235-9.
14. Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS, et al.: Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer. 2005; 104: 511-20.
15. Thompson RH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML, et al.: Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score. J Urol. 2007; 177: 477-80.
16. Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, et al.: Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer. 2005; 103: 2517-25.
17. Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, et al.: Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. J Urol. 2008; 180: 1284-9.
18. Klatte T, Said JW, de Martino M, Larochelle J, Shuch B, Rao JY, et al.: Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification. J Urol. 2009; 181: 1558- 64; discussion 1563-4.
19. Katz MD, Serrano MF, Grubb RL 3rd, Skolarus TA, Gao F, Humphrey PA, et al.: Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. J Urol. 2010; 183: 909-14.
20. Whitson JM, Harris CR, Reese AC, Meng MV: Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases. J Urol. 2011; 185: 1615-20.
21. Bukowski RM. Prognostic factors for survival in metastatic renal cell carcinoma: update 2008. Cancer. 2009; 115(10 Suppl): 2273-81.